Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01283711 · ClinicalTrials.gov registry record · NA
Evaluation of Safety and Efficacy of the Apollo™ System for Treatment of Wrinkles and Rhytides
A NA study, sponsored by Pollogen.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT01283711 is a NA study that has completed, run by Pollogen. The registered enrollment target is 37 participants.
The verdict
NCT01283711, a NA study, has completed, sponsored by Pollogen.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Non-invasive, energy-based, aesthetic treatments are becoming increasingly popular among female and male patients of all ages. Different technologies are presently available to rejuvenate skin, including therapeutic ultrasound, lasers and intense pulsed light (IPL), however radiofrequency has emerged as the most effective and versatile modality for the broadest range of body and facial treatments, including non-invasive wrinkle treatment. The apollo™ system is an RF system, based on the TriPollar™ technology. The technology is based on three or more electrodes designed to deliver RF current focused into the skin, thus generating heat in the dermal layer. Selective and focused electro-heating of the skin is intended to stimulate collagen remodeling in the dermal layer resulting in non invasive wrinkle treatment. The apollo™ system is intended for use in dermatologic and general surgical procedures for non invasive treatment of facial wrinkles and rhytides. This study was designed in order to evaluate the safety and efficacy of the Apollo™ System for facial wrinkles and rhytides treatments.
Interventions
- DEVICE apollo device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01283711
The ClinicalTrials.gov registry entry for NCT01283711 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pollogen, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which apollo device is the first listed.
NCT01283711 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01283711 about?
NCT01283711 is a clinical study titled "Evaluation of Safety and Efficacy of the Apollo™ System for Treatment of Wrinkles and Rhytides". Non-invasive, energy-based, aesthetic treatments are becoming increasingly popular among female and male patients of all ages. Different technologies are presently available to rejuvenate skin, including therapeutic ultrasound, lasers and intense pulsed light (IPL), however radiofrequency has emerge...
What is the current status of trial NCT01283711?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2011-03. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01283711?
The interventions under investigation include: apollo device (DEVICE).
Who is sponsoring clinical trial NCT01283711?
This trial is sponsored by Pollogen, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.